What patents on AI-derived drugs reveal
Science · 29.05.2025 · 388 (6750) · 924-926
DOI: 10.1126/science.adw1972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 29.05.2025. Verfasst von Janet Freilich und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Law, Boston University, Boston, MA, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Development, Patents as Topic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Less in-depth, in vivo testing before patenting may affect overall research and development
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Law, Boston University, Boston, MA, USA.
- School of Law, Center for Innovation Policy, and Duke-Margolis Institute for Health Policy, Duke University, Durham, NC, USA.
Zitieren
APA
Freilich, J., & Rai, A. K. (2025). What patents on AI-derived drugs reveal. Science, 388(6750), 924-926. https://doi.org/10.1126/science.adw1972
Vancouver
Freilich J, Rai AK. What patents on AI-derived drugs reveal. Science. 2025;388(6750):924-926. doi:10.1126/science.adw1972
BibTeX
@article{Freilich2025,
author = {Freilich, Janet and Rai, Arti K},
title = {What patents on AI-derived drugs reveal},
journal = {Science},
year = {2025},
volume = {388},
number = {6750},
pages = {924--926},
doi = {10.1126/science.adw1972}
}
EUVIMED